{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:53:08Z","timestamp":1778809988240,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T20:22:27Z","timestamp":1589142147000},"page":"e375-e387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmaceutical practices before and throughout the opioid crisis: A scoping review"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4778-9876","authenticated-orcid":false,"given":"Naji-Tom","family":"Samaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1973-179X","authenticated-orcid":false,"given":"Marie-Claude","family":"Vanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.japh.2020.03.026_bib4","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.1995.03530230060032","article-title":"Quality improvement guidelines for the treatment of acute pain and cancer pain","volume":"274","author":"Max","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3949\/ccjm.83b.06016","article-title":"The fifth vital sign: a complex story of politics and patient care","volume":"83","author":"Mandell","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2105\/AJPH.2016.303228","article-title":"Are pain management questions in patient satisfaction surveys driving the opioid epidemic?","volume":"106","author":"Adams","year":"2016","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of Oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.japh.2020.03.026_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"issue":"50-51","key":"10.1016\/j.japh.2020.03.026_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.japh.2020.03.026_bib12","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014","volume":"65","author":"Warner","year":"2016","journal-title":"Natl Vital Stat Rep"},{"issue":"8","key":"10.1016\/j.japh.2020.03.026_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/070674371105600808","article-title":"Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review","volume":"56","author":"Amari","year":"2011","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/pop.2013.0098","article-title":"Prescription opioid abuse: a literature review of the clinical and economic burden in the United States","volume":"17","author":"Meyer","year":"2014","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.japh.2020.03.026_bib15","author":"Litton"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.gerinurse.2018.10.003","article-title":"Characteristics associated with transition from opioid initiation to chronic opioid use among opioid-naive older adults","volume":"40","author":"Musich","year":"2019","journal-title":"Geriatr Nurs"},{"issue":"3","key":"10.1016\/j.japh.2020.03.026_bib18","first-page":"533","article-title":"Opportunities and responsibilities in pharmaceutical care","volume":"47","author":"Hepler","year":"1990","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.japh.2020.03.026_bib19","series-title":"Developing Pharmacy Practice: A Focus on Patient Care","author":"Wiedenmayer","year":"2006"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11096-012-9728-x","article-title":"What is \u2018pharmaceutical care\u2019 in 2013?","volume":"35","author":"van Mil","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.japh.2020.03.026_bib21","article-title":"The relational dimensions of pharmaceutical care: experience from caring for HIV-infected asylum seekers in Montreal","author":"David","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"18","key":"10.1016\/j.japh.2020.03.026_bib22","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.japh.2020.03.026_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.japh.2020.03.026_bib24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/ajhp\/61.13.1341","article-title":"Pharmacist-managed pain clinic at a Veterans Affairs Medical Center","volume":"61","author":"Rapoport","year":"2004","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"10.1016\/j.japh.2020.03.026_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1526-4637.2006.00254.x","article-title":"The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse","volume":"8","author":"Wiedemer","year":"2007","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib26","first-page":"484","article-title":"Ideas and innovations: inclusion of pharmacists in chronic pain management services in a primary care practice","volume":"7","author":"Li","year":"2011","journal-title":"J\u00a0Opioid Manag"},{"issue":"16","key":"10.1016\/j.japh.2020.03.026_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2146\/ajhp160294","article-title":"Implementation of a pharmacist-managed clinic for patients with chronic nonmalignant pain","volume":"74","author":"Norman","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"10.1016\/j.japh.2020.03.026_bib28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/ajhp\/61.14.1487","article-title":"Pharmacist interventions in pain management","volume":"61","author":"Lynn","year":"2004","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib29","first-page":"91","article-title":"A\u00a0feasibility study of a combined nurse\/pharmacist-led chronic pain clinic in primary care","volume":"16","author":"Briggs","year":"2008","journal-title":"Qual Prim Care"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/JTN.0000000000000112","article-title":"Pharmacist's impact on acute pain management during trauma resuscitation","volume":"22","author":"Montgomery","year":"2015","journal-title":"J\u00a0Trauma Nurs"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib31","first-page":"38","article-title":"Pilot inpatient pain pharmacist consult service at the West Palm Beach VA Medical Center","volume":"35","author":"Tran","year":"2018","journal-title":"Fed Pract"},{"issue":"16","key":"10.1016\/j.japh.2020.03.026_bib32","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2146\/ajhp070597","article-title":"Pain management pharmacy service in a community hospital","volume":"65","author":"Fan","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.japh.2020.03.026_bib33","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/ijcp.12311","article-title":"Implementation of a pharmacist-driven pain management consultation service for hospitalised adults with a history of substance abuse","volume":"67","author":"Andrews","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"2S","key":"10.1016\/j.japh.2020.03.026_bib34","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.japh.2017.01.016","article-title":"Opioid exit plan: a pharmacist's role in managing acute postoperative pain","volume":"57","author":"Genord","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2146\/ajhp060056","article-title":"Provision of pain management by a pharmacist with prescribing authority","volume":"64","author":"Dole","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"2S","key":"10.1016\/j.japh.2020.03.026_bib36","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.japh.2017.01.005","article-title":"Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone","volume":"57","author":"Duvivier","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2020.03.026_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jcpt.12540","article-title":"Impact of pharmacists assisting with prescribing and undertaking medication review on oxycodone prescribing and supply for patients discharged from surgical wards","volume":"42","author":"Tran","year":"2017","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib38","first-page":"551","article-title":"Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice","volume":"185","author":"Bates","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.japh.2020.03.026_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamadermatol.2013.1871","article-title":"Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients","volume":"149","author":"Harris","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2S","key":"10.1016\/j.japh.2020.03.026_bib40","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.japh.2017.01.010","article-title":"The impact of pharmacy services on opioid prescribing in dental practice","volume":"57","author":"Stewart","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"7576","key":"10.1016\/j.japh.2020.03.026_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.38977.590752.0B","article-title":"Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial","volume":"333","author":"Hay","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08897077.2015.1129527","article-title":"Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014\u2013March 31, 2015","volume":"37","author":"Jacobs","year":"2016","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.japh.2020.03.026_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4321\/S1886-36552009000200004","article-title":"Education for arthritis patients: a community pharmacy based pilot project","volume":"7","author":"Petkova","year":"2009","journal-title":"Pharm Pract (Granada)"},{"issue":"12","key":"10.1016\/j.japh.2020.03.026_bib44","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1345\/aph.1K635","article-title":"Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention","volume":"42","author":"Hoffmann","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2S","key":"10.1016\/j.japh.2020.03.026_bib45","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.japh.2016.12.075","article-title":"A\u00a0nationwide pharmacy chain responds to the opioid epidemic","volume":"57","author":"Shafer","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.japh.2020.03.026_bib46","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.sapharm.2018.07.011","article-title":"Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk","volume":"15","author":"Strand","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"2S","key":"10.1016\/j.japh.2020.03.026_bib47","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.japh.2017.01.021","article-title":"The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department","volume":"57","author":"Winstanley","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"11","key":"10.1016\/j.japh.2020.03.026_bib48","first-page":"515","article-title":"A\u00a0randomized, pragmatic, pharmacist-led intervention reduced opioids following orthopedic surgery","volume":"24","author":"Smith","year":"2018","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.japh.2020.03.026_bib49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11192-010-0202-z","article-title":"The rate of growth in scientific publication and the decline in coverage provided by science citation index","volume":"84","author":"Larsen","year":"2010","journal-title":"Scientometrics"},{"key":"10.1016\/j.japh.2020.03.026_bib50","series-title":"The STM Report: An Overview of Scientific and Scholarly Journal Publishing","author":"Ware","year":"2015"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib51","first-page":"CD000072","article-title":"Interprofessional collaboration to improve professional practice and healthcare outcomes","volume":"6","author":"Reeves","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.japh.2020.03.026_bib53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/phar.1719","article-title":"Evaluation of the impact of a pharmacist-led telehealth clinic on diabetes-related goals of therapy in a veteran population","volume":"36","author":"Maxwell","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.japh.2020.03.026_bib54","first-page":"4105","article-title":"Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study","volume":"26","author":"Whitman","year":"2018","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3122\/jabfm.2018.01.170210","article-title":"Impact of pharmacist previsit input to providers on chronic opioid prescribing safety","volume":"31","author":"Cox","year":"2018","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"5","key":"10.1016\/j.japh.2020.03.026_bib56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/pme.12332","article-title":"Degree of knowledge of health care professionals about pain management and use of opioids in pediatrics","volume":"15","author":"de Freitas","year":"2014","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.japh.2020.03.026_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157151","article-title":"Knowledge, perceptions and attitudes toward chronic pain and its management: a cross-sectional survey of frontline pharmacists in Ontario, Canada","volume":"11","author":"Patel","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.japh.2020.03.026_bib58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0897190014522064","article-title":"Pharmacists who screen and discuss opioid misuse with patients: future directions for research and practice","volume":"28","author":"Cochran","year":"2015","journal-title":"J\u00a0Pharm Pract"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sapharm.2012.03.003","article-title":"Opinions and experiences of Indiana pharmacists and student pharmacists: the need for addiction and substance abuse education in the United States","volume":"9","author":"Wenthur","year":"2013","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.japh.2020.03.026_bib60","first-page":"163","article-title":"Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists","volume":"7","author":"Jouini","year":"2014","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2014.11.006","article-title":"Factors associated with provision of addiction treatment information by community pharmacists","volume":"52","author":"Hagemeier","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"7","key":"10.1016\/j.japh.2020.03.026_bib64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/papr.12532","article-title":"Safety and efficacy of a pharmacist-managed patient-controlled analgesia service in postsurgical patients","volume":"17","author":"McGonigal","year":"2017","journal-title":"Pain Pract"},{"key":"10.1016\/j.japh.2020.03.026_bib65","author":"Norman"},{"key":"10.1016\/j.japh.2020.03.026_bib66","author":"Morrison"},{"issue":"9","key":"10.1016\/j.japh.2020.03.026_bib67","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/pm\/pnx139","article-title":"Pharmacists' role in opioid safety: a focus group investigation","volume":"19","author":"Hartung","year":"2018","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2016.11.003","article-title":"Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement","volume":"73","author":"Stumbo","year":"2017","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.japh.2020.03.026_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08897077.2017.1365803","article-title":"Interprofessional prescription opioid abuse communication among prescribers and pharmacists: a qualitative analysis","volume":"39","author":"Hagemeier","year":"2018","journal-title":"Subst Abus"},{"issue":"8","key":"10.1016\/j.japh.2020.03.026_bib70","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.sapharm.2018.08.006","article-title":"Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis","volume":"15","author":"Curran","year":"2019","journal-title":"Res Social Adm Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120301564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120301564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:51:46Z","timestamp":1761544306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120301564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120301564"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.03.026","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical practices before and throughout the opioid crisis: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}